Ted Yednock, EVP & Chief Scientific Officer at Annexon, Inc. (ANNX), sold 32,113 shares at $28.54 ($924K) on 2021-03-25, disclosed to the SEC on 2021-03-29.
Open-market sale of $924k ANNX by EVP & Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.54 | 10,258 | $293K | 31.7% |
| 2 | $28.54 | 10,258 | $293K | 31.7% |
| 3 | $29.21 | 5,680 | $166K | 17.9% |
| 4 | $29.21 | 5,680 | $166K | 17.9% |
| 5 | $29.96 | 237 | $7K | 0.8% |
| Total | $28.79 avg | 32,113 |
| $924K |
| 100% |
| Filing → |
| ANNX | SELL | 2025-07-16 | $3K | — | Filing → |
| ANNX | SELL | 2025-02-20 | $24K | — | Filing → |
| ANNX | SELL | 2025-02-18 | $5K | — | Filing → |